Welcome to our dedicated page for Zoetis SEC filings (Ticker: ZTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Zoetis Inc. filings document the animal health company's operating results, capital returns, financing activity and governance disclosures. Recent 8-K reports furnish quarterly and annual financial results, guidance, dividend declarations, investor presentations and other Regulation FD disclosures.
The company's proxy materials address board and compensation matters, including executive pay and equity-award disclosures. Other filings record its New York Stock Exchange-listed common stock and debt financing, including a private offering of convertible senior notes, related indenture terms and capped call transactions.
Zoetis Inc. director Gregory Norden reported a bona fide gift of 1,213 shares of Zoetis common stock on March 9, 2026. The shares were transferred to a trust for which he serves as trustee. Following this transfer, he holds Zoetis shares indirectly through personal and family trusts.
Zoetis Inc. director Michael B. McCallister reported equity award activity involving restricted stock units (RSUs) and common shares. On February 19, he exercised RSUs covering 1,619.3325 units at a price of $0.00 per unit, receiving 1,619 common shares. A separate entry shows 413 common shares transferred to Zoetis in exchange for cash based on the $127.28 closing share price on the vesting date. After these transactions, he directly held 1,209 common shares and 1,936 RSUs, with additional indirect holdings of 21,524 and 6,160 common shares held by family trusts.
Zoetis Inc. director Gregory Norden reported equity award activity involving restricted stock units (RSUs) and common shares. He exercised or converted 1,619.3325 RSUs, resulting in the acquisition of 1,619 common shares of Zoetis stock at a stated price of $0.00 per share, reflecting settlement of equity awards rather than an open-market purchase.
As part of the same event, 406 common shares were disposed of back to Zoetis in exchange for cash based on the closing share price of $127.28 per share on the vesting date, typically to cover obligations such as taxes. After these transactions, Norden directly held 1,213 common shares and 1,936 RSUs, and also had indirect ownership through a personal trust and separate trusts for his daughter and son, which together hold several thousand additional Zoetis common shares.
Zoetis Inc. director Vanessa Broadhurst reported equity compensation activity involving restricted stock units (RSUs) and common shares. On February 19, 2026, RSUs covering about 1,619 shares were exercised and converted into 1,619 shares of Zoetis common stock at a price of $0.00 per share. A separate transaction involving 517 common shares at $127.28 per share was reported as an other acquisition or disposition, with a footnote explaining these shares were transferred back to Zoetis in exchange for cash based on the closing share price on the vesting date. After these movements, she directly holds 3,920 shares of Zoetis common stock and 1,936 RSUs that each represent a contingent right to receive one share of common stock, generally vesting on the first anniversary of the grant date if service conditions are met.
Zoetis Inc. Executive Vice President Julie Fuller reported equity award activity tied to restricted stock units (RSUs). On February 19, 2026, RSUs converted into 750 shares of common stock at a stated price of $0.0000 per share, reflecting vesting and settlement of RSUs. On the same date, 290 common shares were disposed of at $127.2800 per share to cover tax obligations through a tax-withholding disposition. Footnotes explain that each RSU represents a right to receive one Zoetis common share, with one-third of each RSU grant generally vesting on each of the first, second, and third anniversaries of the grant dates, subject to continued service and certain earlier vesting events.
Zoetis Inc. Chief Financial Officer Joseph Wetteny reported equity compensation activity involving restricted stock units (RSUs) and common shares on February 19, 2026. RSUs representing 2,050.6517 units were exercised and converted, resulting in the acquisition of 2,050 common shares at a stated price of $0.00 per share as part of vesting and settlement.
To satisfy tax obligations tied to this vesting, 703 common shares were disposed of at $127.28 per share through tax withholding. After these transactions, Wetteny directly owned 22,113 shares of Zoetis common stock. He also held outstanding RSU awards that, after the reported activity, totaled 8,605 RSUs and 1,389 RSUs under separate grants, each generally vesting in one‑third increments on the first, second, and third anniversaries of their respective grant dates, subject to continued service and certain earlier‑vesting events.
Zoetis Inc. reports that Chief Executive Officer Kristin C. Peck acquired 7,354 shares of common stock on February 19, 2026 through the vesting and settlement of restricted stock units (RSUs), delivered at a $0.00 exercise price.
On the same date, 3,623 of those shares were withheld by the company at $127.28 per share to satisfy tax obligations associated with the RSU vesting. After these transactions, she directly holds 105,068 shares of Zoetis common stock and 48,336 RSUs, in addition to 833.6435 common-stock equivalents held indirectly in the Zoetis Savings Plan. Footnotes state that each RSU represents one share and that RSU grants under the Zoetis Amended and Restated 2013 Equity and Incentive Plan vest in three equal annual installments, subject to continued service.
Zoetis Inc. Executive Vice President Nicholas Ashton reported equity award activity involving restricted stock units (RSUs) and common shares. On February 19, he acquired 750 shares of Zoetis common stock at $0.0000 per share through the exercise and settlement of RSUs, with 2,214 common shares held directly after this step.
On the same date, 392 common shares at $127.2800 per share were disposed of to satisfy tax withholding obligations related to the vesting event, leaving 1,822 common shares held directly. Footnotes explain that each RSU converts into one Zoetis common share and vests in three annual installments following the original grant dates, subject to continued service and certain specified events.
Zoetis Inc. director Gavin Hattersley reported equity award activity involving restricted stock units (RSUs) and common shares. On February 19, 2026, RSUs covering 1,619.3325 units were exercised and converted into 1,619 common shares of Zoetis common stock at a stated price of $0.00 per share.
Following this conversion, Hattersley directly held 3,835 common shares, then disposed of 481 shares back to Zoetis in exchange for cash based on the closing share price of $127.28 per share, leaving 3,354 common shares held directly. The filing also shows a holding of 1,936 RSUs granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, each RSU representing a contingent right to receive one Zoetis common share upon vesting on its stated first-anniversary dates, subject to continued service and certain early vesting conditions.
Zoetis Inc. Executive Vice President Roxanne Lagano reported equity award activity involving restricted stock units and common shares. On February 19, 2026, she acquired 750.4257 restricted stock units through an exercise or conversion, resulting in 1,500 restricted stock units directly held after the transaction.
On the same date, she acquired 750 shares of Zoetis common stock upon vesting and settlement of restricted stock units, bringing her directly held common stock to 15,890 shares before tax withholding. To satisfy tax obligations, 258 shares of common stock were disposed of at $127.28 per share in a tax-withholding transaction, leaving 15,632 common shares held directly.
In addition to common shares, Lagano holds 3,664 restricted stock units and 545 restricted stock units from separate awards, each RSU representing a contingent right to receive one share of Zoetis common stock, with vesting generally in one-third installments on the first, second and third anniversaries of the applicable grant dates. She also indirectly holds 833.684 common stock equivalents through the Zoetis Inc. Savings Plan, a 401(k) plan, as of December 31, 2025.